# Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

> **NCT00358735** · NA · COMPLETED · sponsor: **Medical Compression Systems** · enrollment: 411 (actual)

## Conditions studied

- Deep Vein Thrombosis of Lower Limb
- Pulmonary Embolism (PE)
- Bleeding

## Interventions

- **DEVICE:** ActiveCare CECT device
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT00358735
- **Lead sponsor:** Medical Compression Systems
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-09
- **Final completion:** 2008-12
- **Target enrollment:** 411 (ACTUAL)
- **Last updated:** 2014-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358735, "Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00358735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*